Bio Impact Capital LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $552 Million distributed in 40 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Madrigal Pharmaceuticals, Inc. with a value of $46.1M, Cullinan Oncology, Inc. with a value of $45.4M, Avidity Biosciences, Inc. with a value of $33.1M, Trevi Therapeutics, Inc. with a value of $30.5M, and Edgewise Therapeutics, Inc. with a value of $27.9M.
Examining the 13F form we can see an increase of $41.6M in the current position value, from $511M to 552M.
Bio Impact Capital LLC is based out at Cambridge, MA
Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.
